Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|May 27, 2022
Gene Engineering T Cells with T-Cell Receptor for Adoptive TherapyDian Kortleve, Mandy van Brakel, Rebecca Wijers, et al.Journal for Immunotherapy of Cancer|April 21, 2016
Enhanced recruitment of genetically modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradientImran Siddiqui, Marco Erreni, Mandy van Brakel, et al.Cancers|May 21, 2020
T Cells Expressing a TCR-Like Antibody Selected Against the Heteroclitic Variant of a Shared MAGE-A Epitope Do Not Recognise the Cognate EpitopeMesha Saeed, Erik Schooten, Mandy van Brakel, et al.Journal of Neuro-Oncology|June 27, 2019
Lack of B and T cell reactivity towards IDH1R132H in blood and tumor tissue from LGG patientsBas Weenink, Mandy van Brakel, Rebecca Wijers, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2016
MAGE-C2-Specific TCRs Combined with Epigenetic Drug-Enhanced Antigenicity Yield Robust and Tumor-Selective T Cell ResponsesAndre Kunert, Mandy van Brakel, Sabine van Steenbergen-Langeveld, et al.International Journal of Nanomedicine|March 30, 2016
Targeting melanoma with immunoliposomes coupled to anti-MAGE A1 TCR-like single-chain antibodyMesha Saeed, Mandy van Brakel, Sara Zalba, et al.International Journal of Nanomedicine|April 6, 2026
Multivalent Atezolizumab-Liposome Conjugates as Active Immunotherapeutic Platforms for Enhanced PD-L1 Blockade in MelanomaZiyun Cheng, Mohamadreza Amin, Mandy van Brakel, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 17, 2014
TCRs genetically linked to CD28 and CD3ε do not mispair with endogenous TCR chains and mediate enhanced T cell persistence and anti-melanoma activityCoen Govers, Zsolt Sebestyén, János Roszik, et al.Clinical & Developmental Immunology|March 9, 2012
TCR gene transfer: MAGE-C2/HLA-A2 and MAGE-A3/HLA-DP4 epitopes as melanoma-specific immune targetsTrudy Straetemans, Mandy van Brakel, Sabine van Steenbergen, et al.Human Gene Therapy Methods|November 26, 2014
T cell receptor-engineered T cells to treat solid tumors: T cell processing toward optimal T cell fitnessCor H J Lamers, Sabine van Steenbergen-Langeveld, Mandy van Brakel, et al.Pageof 2